Xin Ming to Neoplasms
This is a "connection" page, showing publications Xin Ming has written about Neoplasms.
Connection Strength
2.144
-
Mao C, Yeh S, Fu J, Porosnicu M, Thomas A, Kucera GL, Votanopoulos KI, Tian S, Ming X. Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression. Sci Transl Med. 2022 Jun 08; 14(648):eabh1261.
Score: 0.508
-
Mao C, Li F, Zhao Y, Debinski W, Ming X. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment. Theranostics. 2018; 8(22):6274-6290.
Score: 0.398
-
Mao C, Zhao Y, Li F, Li Z, Tian S, Debinski W, Ming X. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. J Control Release. 2018 09 28; 286:289-300.
Score: 0.389
-
Zhao Y, Li F, Mao C, Ming X. Multiarm Nanoconjugates for Cancer Cell-Targeted Delivery of Photosensitizers. Mol Pharm. 2018 07 02; 15(7):2559-2569.
Score: 0.385
-
Wang M, Mao C, Wang H, Ling X, Wu Z, Li Z, Ming X. Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe. Mol Pharm. 2017 10 02; 14(10):3391-3398.
Score: 0.365
-
Mao C, Qu P, Miley MJ, Zhao Y, Li Z, Ming X. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates. Biomater Sci. 2018 Oct 24; 6(11):3063-3074.
Score: 0.099